Gefitinib the Erda for Lashmaxxing

roidboy

roidboy

high inhib hell
Joined
Mar 4, 2026
Posts
45
Reputation
39
Gefitinib the Erda for eyelashes

Gefetinib 7


We will be using a lung cancer drug to grow the most slayer lashes and potentially brows due to drug induced trichomegaly (retarded don't actually do this)
GH6GhaiXIAA Lg2



THE SCIENCE
===========================================

Gefitinib is an EGFR inhibitor. It's a cancer drug for non-small cell lung cancer. The side effect they noticed in patients? Insane lash growth. Like, touching-their-brows type growth.

EGFR is basically the off switch for hair follicles. Block it, and follicles stay in growth phase longer. Lashes get longer, thicker, darker, and curly. It's documented in medical journals, not bro-science.

43440 2020 131 Fig1 HTML


The Timeline: Patients report trichomegaly (defined as lashes reaching 12mm or longer) starting around 2-5 months after starting treatment.

Icot a 636118 f0001 b
Images 9

More examples of genetic trichomegaly.
Ijdvl 2016 82 6 700 187690 f1
Images 10


Case Examples:

· A 52-year-old female lung cancer patient on 250mg/day gefitinib developed trichomegaly at 3 months
· A 47-year-old female on erlotinib (same class) had confirmed lash regression after stopping
· An 82-year-old female developed dense corneal erosion from lashes rubbing her eye after 6 months on gefitinib

===========================================
THE DOSING
===========================================

Standard cancer dose is 250 mg once daily, orally. That's it. There's no established lower dose for cosmetic use because nobody's studied it for that. You're taking the same dose as a lung cancer patient.

For patients who can't swallow tablets: The tablet can be dispersed in 4-8 ounces of water by dropping it in and stirring for ~15 minutes. Not recommending it—just saying it's documented.

===========================================
SIDE EFFECTS (Read This Twice)
===========================================

This is where it gets real. This isn't Latisse eye drops. You're taking a systemic drug. Here's what you're signing up for, straight from the FDA label:

VERY COMMON (more than 10%):

· Diarrhea (Grade 3 or 4 in 3% of patients)
· Nausea and vomiting
· Acneiform rash on face and upper torso
· Dry skin, itching, peeling
· Nail changes (painful, brittle, ingrown)
· Mouth ulcers and stomatitis
· Loss of appetite and fatigue

LIVER TOXICITY: 11.4% had increased ALT, 7.9% had increased AST, 2.7% had increased bilirubin. Grade 3 or higher liver abnormalities occurred in 5.1% of patients. Fatal hepatotoxicity occurred in 0.04%.

LASH-RELATED (the "good" side effects):

· Trichomegaly (long lashes)
· Curling and thickening
· Aberrant eyelash growth leading to corneal erosion (0.2% of patients)
· Keratitis (eye inflammation, 0.1%)
· Conjunctivitis, dry eye (6.7%)

RARE BUT SERIOUS (could kill you):

· Interstitial lung disease (ILD): Occurred in 1.3% of 2462 patients. 0.7% were Grade 3 or higher. 3 cases were fatal. Symptoms: shortness of breath, cough, fever. If you get this, stop immediately and go to a hospital.
· Gastrointestinal perforation (0.1% of patients)
· Toxic epidermal necrolysis/Stevens-Johnson syndrome (rare but fatal skin reactions)

The kicker: If you get the rash, that actually means you're absorbing it well. Cancer patients with rash respond better to treatment. So congratulations—you now have diarrhea, acne, and luscious lashes.

===========================================
DRUG INTERACTIONS
===========================================

You can't just take this with anything. Here's what messes with it:

Strong CYP3A4 inducers: Rifampin, phenytoin, carbamazepine, St. John's Wort
-> Effect: Reduces efficacy—may need higher dose

Strong CYP3A4 inhibitors: Ketoconazole, grapefruit juice, clarithromycin
-> Effect: Increases toxicity risk

Acid reducers: Proton-pump inhibitors, H2 antagonists, antacids
-> Effect: Reduces absorption and efficacy

Warfarin: Blood thinner
-> Effect: Increased bleeding risk—monitor INR

Also don't take St. John's Wort or grapefruit juice. Both mess with drug levels.

===========================================
REAL CASE EXAMPLES
===========================================

[Insert image: Patient with trichomegaly on gefitinib]
[Image description: Close-up of patient's eyes with overgrown lashes]

Case 1: 52yo female lung cancer patient on 250mg/day. At 3 months, re-evaluation showed good partial response to treatment. Routine follow-up revealed enlarged eyelashes she hadn't even noticed. No diarrhea or skin rash. She was advised to continue treatment with monthly trimming of eyelashes.

Case 2: 47yo Syrian woman on gefitinib/erlotinib for 42 months achieved complete response. Developed eyelash trichomegaly, managed with occasional trimming. When erlotinib was discontinued, lashes regressed.

Case 3: 82yo female on gefitinib for 6 months. Presented with eye pain, hyperemic conjunctiva, and dense corneal erosion from lashes rubbing her eye. The elongation was severe.

===========================================
THE RISK-REWARD RATIO
===========================================

Look, I'm not your dad. But this is objectively regarded. You're taking a prescription cancer drug with systemic toxicity to get long lashes.

Alternative: Latisse (bimatoprost) is FDA-approved for lash growth. Safer. Topical. Costs more but won't give you diarrhea or liver damage.

Verdict: The data says it works. The side effect profile says you're an idiot if you do it.

===========================================
SOURCES
===========================================

· DailyMed FDA Label: dailymed.nlm.nih.gov for full prescribing info
· Case report: Journal of Medical Case Reports (2026) – 47yo patient with TKI-induced trichomegaly
· Case report: International Journal of Trichology (2018) – 52yo female on gefitinib
· Korean Ophthalmological Society case report (2014) – 82yo female with corneal erosion from lashes
· Dermatology Online Journal (2009) – Review of EGFR inhibition and hair growth

===========================================
DISCLAIMER
===========================================

This isn't medical advice. Gefitinib is for cancer treatment, not cosmetic use. Self-administering it is genuinely dangerous. If you actually do this, don't say I didn't warn you.

===========================================
Good luck, boyos. May your lashes be long and your organs be intact.
===========================
 
Last edited:
  • +1
Reactions: Attila The Hun and onepiecee
Gefitinib the Erda for eyelashes

View attachment 5605721

We will be using a lung cancer drug to grow the most slayer lashes and potentially brows due to drug induced trichomegaly (retarded don't actually do this)
View attachment 5605751


THE SCIENCE
===========================================

Gefitinib is an EGFR inhibitor. It's a cancer drug for non-small cell lung cancer. The side effect they noticed in patients? Insane lash growth. Like, touching-their-brows type growth.

EGFR is basically the off switch for hair follicles. Block it, and follicles stay in growth phase longer. Lashes get longer, thicker, darker, and curly. It's documented in medical journals, not bro-science.

View attachment 5605756

The Timeline: Patients report trichomegaly (defined as lashes reaching 12mm or longer) starting around 2-5 months after starting treatment.

View attachment 5605762 View attachment 5605766
More examples of genetic trichomegaly.
View attachment 5605773View attachment 5605774

Case Examples:

· A 52-year-old female lung cancer patient on 250mg/day gefitinib developed trichomegaly at 3 months
· A 47-year-old female on erlotinib (same class) had confirmed lash regression after stopping
· An 82-year-old female developed dense corneal erosion from lashes rubbing her eye after 6 months on gefitinib

===========================================
THE DOSING
===========================================

Standard cancer dose is 250 mg once daily, orally. That's it. There's no established lower dose for cosmetic use because nobody's studied it for that. You're taking the same dose as a lung cancer patient.

For patients who can't swallow tablets: The tablet can be dispersed in 4-8 ounces of water by dropping it in and stirring for ~15 minutes. Not recommending it—just saying it's documented.

===========================================
SIDE EFFECTS (Read This Twice)
===========================================

This is where it gets real. This isn't Latisse eye drops. You're taking a systemic drug. Here's what you're signing up for, straight from the FDA label:

VERY COMMON (more than 10%):

· Diarrhea (Grade 3 or 4 in 3% of patients)
· Nausea and vomiting
· Acneiform rash on face and upper torso
· Dry skin, itching, peeling
· Nail changes (painful, brittle, ingrown)
· Mouth ulcers and stomatitis
· Loss of appetite and fatigue

LIVER TOXICITY: 11.4% had increased ALT, 7.9% had increased AST, 2.7% had increased bilirubin. Grade 3 or higher liver abnormalities occurred in 5.1% of patients. Fatal hepatotoxicity occurred in 0.04%.

LASH-RELATED (the "good" side effects):

· Trichomegaly (long lashes)
· Curling and thickening
· Aberrant eyelash growth leading to corneal erosion (0.2% of patients)
· Keratitis (eye inflammation, 0.1%)
· Conjunctivitis, dry eye (6.7%)

RARE BUT SERIOUS (could kill you):

· Interstitial lung disease (ILD): Occurred in 1.3% of 2462 patients. 0.7% were Grade 3 or higher. 3 cases were fatal. Symptoms: shortness of breath, cough, fever. If you get this, stop immediately and go to a hospital.
· Gastrointestinal perforation (0.1% of patients)
· Toxic epidermal necrolysis/Stevens-Johnson syndrome (rare but fatal skin reactions)

The kicker: If you get the rash, that actually means you're absorbing it well. Cancer patients with rash respond better to treatment. So congratulations—you now have diarrhea, acne, and luscious lashes.

===========================================
DRUG INTERACTIONS
===========================================

You can't just take this with anything. Here's what messes with it:

Strong CYP3A4 inducers: Rifampin, phenytoin, carbamazepine, St. John's Wort
-> Effect: Reduces efficacy—may need higher dose

Strong CYP3A4 inhibitors: Ketoconazole, grapefruit juice, clarithromycin
-> Effect: Increases toxicity risk

Acid reducers: Proton-pump inhibitors, H2 antagonists, antacids
-> Effect: Reduces absorption and efficacy

Warfarin: Blood thinner
-> Effect: Increased bleeding risk—monitor INR

Also don't take St. John's Wort or grapefruit juice. Both mess with drug levels.

===========================================
REAL CASE EXAMPLES
===========================================

[Insert image: Patient with trichomegaly on gefitinib]
[Image description: Close-up of patient's eyes with overgrown lashes]

Case 1: 52yo female lung cancer patient on 250mg/day. At 3 months, re-evaluation showed good partial response to treatment. Routine follow-up revealed enlarged eyelashes she hadn't even noticed. No diarrhea or skin rash. She was advised to continue treatment with monthly trimming of eyelashes.

Case 2: 47yo Syrian woman on gefitinib/erlotinib for 42 months achieved complete response. Developed eyelash trichomegaly, managed with occasional trimming. When erlotinib was discontinued, lashes regressed.

Case 3: 82yo female on gefitinib for 6 months. Presented with eye pain, hyperemic conjunctiva, and dense corneal erosion from lashes rubbing her eye. The elongation was severe.

===========================================
THE RISK-REWARD RATIO
===========================================

Look, I'm not your dad. But this is objectively regarded. You're taking a prescription cancer drug with systemic toxicity to get long lashes.

Alternative: Latisse (bimatoprost) is FDA-approved for lash growth. Safer. Topical. Costs more but won't give you diarrhea or liver damage.

Verdict: The data says it works. The side effect profile says you're an idiot if you do it.

===========================================
SOURCES
===========================================

· DailyMed FDA Label: dailymed.nlm.nih.gov for full prescribing info
· Case report: Journal of Medical Case Reports (2026) – 47yo patient with TKI-induced trichomegaly
· Case report: International Journal of Trichology (2018) – 52yo female on gefitinib
· Korean Ophthalmological Society case report (2014) – 82yo female with corneal erosion from lashes
· Dermatology Online Journal (2009) – Review of EGFR inhibition and hair growth

===========================================
DISCLAIMER
===========================================

This isn't medical advice. Gefitinib is for cancer treatment, not cosmetic use. Self-administering it is genuinely dangerous. If you actually do this, don't say I didn't warn you.

===========================================
Good luck, boyos. May your lashes be long and your organs be intact.
===========================
tir
 
So stupid
 
  • +1
Reactions: Azi.org

Similar threads

T
Replies
1
Views
46
Satly
Satly
C
Replies
5
Views
79
aeioutoo
aeioutoo
.cc
Replies
2
Views
49
Wesk Yg
W
C
Replies
2
Views
54
bloodysummoningg
bloodysummoningg
thisusernameiscool1
Replies
4
Views
90
thisusernameiscool1
thisusernameiscool1

Users who are viewing this thread

Back
Top